✦ LIBER ✦

Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

✍ Scribed by Batty, G.-D.; Li, Q.; Huxley, R.; Zoungas, S.; Taylor, B.-A.; Neal, B.; de Galan, B.; Woodward, M.; Harrap, S.-B.; Colagiuri, S.; Patel, A.; Chalmers, J.

Book ID: 122827248
Publisher: Elsevier Science
Year: 2013
Tongue: French
Weight: 226 KB
Volume: 28
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2011.07.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral disease and subsequent cardiovascul

Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

✍ Q. Li; J. Chalmers; S. Czernichow; B. Neal; B. A. Taylor; S. Zoungas; N. Poulter 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 145 KB

Erectile Dysfunction and Later Cardiovas

Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) Trial

✍ G. David Batty; Qiang Li; Sébastien Czernichow; Bruce Neal; Sophia Zoungas; Rach 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Re: Erectile Dysfunction and Later Cardi

Re: Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) Trial

✍ Seftel, Allen 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 58 KB

Cognitive function and risks of cardiova

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

✍ B. E. de Galan; S. Zoungas; J. Chalmers; C. Anderson; C. Dufouil; A. Pillai; M. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB

The Framingham and UK Prospective Diabet

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study

✍ A. P. Kengne; A. Patel; S. Colagiuri; S. Heller; P. Hamet; M. Marre; C. Y. Pan; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 217 KB